Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.,Ltd engages in the research and development, production, and sales of chemical raw materials and pharmaceutical preparations in China. The company provides drugs for the treatment of anemia, mental disorders, anti-psychotic disorders, cardiovascular and cerebrovascular diseases, and tumors. It provides drugs in the form of tablets and … Read more
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) - Total Assets
Latest total assets as of September 2025: CN¥1.05 Billion CNY
Based on the latest financial reports, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (301130) holds total assets worth CN¥1.05 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd - Total Assets Trend (2011–2024)
This chart illustrates how Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's total assets of CN¥1.05 Billion consist of 35.1% current assets and 64.9% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.9% |
| Accounts Receivable | CN¥61.39 Million | 5.8% |
| Inventory | CN¥27.97 Million | 2.6% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥99.85 Million | 9.4% |
| Goodwill | CN¥30.57 Million | 2.9% |
Asset Composition Trend (2011–2024)
This chart illustrates how Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's current assets represent 35.1% of total assets in 2024, a decrease from 43.4% in 2011.
- Cash Position: Cash and equivalents constituted 17.9% of total assets in 2024, down from 21.6% in 2011.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 2.0% in 2011.
- Asset Diversification: The largest asset category is intangible assets at 9.4% of total assets.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd Competitors by Total Assets
Key competitors of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Swedish Orphan Biovitrum AB (publ)
PINK:BIOVF
|
USA | $67.26 Billion |
|
Kamada
NASDAQ:KMDA
|
USA | $378.79 Million |
|
One World Pharma Inc
OTCQB:OWPC
|
USA | $6.62 Million |
|
Dongwha Pharm.Co.Ltd
KO:000020
|
Korea | ₩654.63 Billion |
|
Shenzhen Neptunus Bioengineering Co Ltd
SHE:000078
|
China | CN¥27.28 Billion |
|
Yuhan Corp.
KO:000100
|
Korea | ₩3.05 Trillion |
|
Anhui Fengyuan Pharmaceutical Co Ltd
SHE:000153
|
China | CN¥4.97 Billion |
|
Kotra Industries Bhd
KLSE:0002
|
Malaysia | RM363.90 Million |
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd generates 0.24x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd generates $ 3.79 in net profit.
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.30 | 8.89 | 6.75 |
| Quick Ratio | 5.84 | 8.43 | 6.24 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥298.93 Million | CN¥ 399.15 Million | CN¥ 228.72 Million |
Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd - Advanced Valuation Insights
This section examines the relationship between Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.63 |
| Latest Market Cap to Assets Ratio | 0.16 |
| Asset Growth Rate (YoY) | -0.4% |
| Total Assets | CN¥1.06 Billion |
| Market Capitalization | $168.69 Million USD |
Valuation Analysis
Below Book Valuation: The market values Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's assets below their book value (0.16 x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd's assets decreased by 0.4% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd (2011–2024)
The table below shows the annual total assets of Jilin Province Xidian Pharmaceutical Sci-Tech Development Co.Ltd from 2011 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥1.06 Billion | -0.43% |
| 2023-12-31 | CN¥1.07 Billion | +4.94% |
| 2022-12-31 | CN¥1.02 Billion | +71.04% |
| 2021-12-31 | CN¥594.61 Million | +7.96% |
| 2020-12-31 | CN¥550.76 Million | +3.77% |
| 2019-12-31 | CN¥530.76 Million | +5.81% |
| 2018-12-31 | CN¥501.64 Million | +6.54% |
| 2017-12-31 | CN¥470.83 Million | +65.74% |
| 2014-12-31 | CN¥284.08 Million | -0.14% |
| 2013-12-31 | CN¥284.49 Million | +18.94% |
| 2012-12-31 | CN¥239.18 Million | +5.26% |
| 2011-12-31 | CN¥227.23 Million | -- |